4//SEC Filing
Evans John M. 4
Accession 0000950170-24-079065
CIK 0001745999other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:15 PM ET
Size
5.8 KB
Accession
0000950170-24-079065
Insider Transaction Report
Form 4
Evans John M.
DirectorCEO
Transactions
- Sale
Common Stock
2024-06-27$24.50/sh−60,000$1,470,156→ 998,343 total
Holdings
- 103,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.17 to $24.93, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Beam Therapeutics Inc.
CIK 0001745999
Entity typeother
Related Parties
1- filerCIK 0001786304
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 4:15 PM ET
- Size
- 5.8 KB